Maternal spindle transfer overcomes embryo developmental arrest caused by ooplasmic defects in mice

  1. Nuno Costa-Borges  Is a corresponding author
  2. Katharina Spath
  3. Irene Miguel-Escalada
  4. Enric Mestres
  5. Rosa Balmaseda
  6. Anna Serafín
  7. Maria Garcia-Jiménez
  8. Ivette Vanrell
  9. Jesús González
  10. Klaus Rink
  11. Dagan Wells
  12. Gloria Calderón
  1. Embryotools SL, Spain
  2. University of Oxford, United Kingdom
  3. Centre for Genomic Regulation, Spain
  4. Parc Cientific de Barcelona, Spain

Abstract

The developmental potential of early embryos is mainly dictated by the quality of the oocyte. Here, we explore the utility of the maternal spindle transfer (MST) technique as a reproductive approach to enhance oocyte developmental competence. Our proof-of-concept experiments show that replacement of the entire cytoplasm of oocytes from a sensitive mouse strain overcomes massive embryo developmental arrest characteristic of non-manipulated oocytes. Genetic analysis confirmed minimal carryover of mtDNA following MST. Resulting mice showed low heteroplasmy levels in multiple organs at adult age, normal histology and fertility. Mice were followed for 5 generations (F5), revealing that heteroplasmy was reduced in F2 mice and was undetectable in the subsequent generations. This pre-clinical model demonstrates the high efficiency and potential of the MST technique, not only to prevent the transmission of mtDNA mutations, but also as a new potential treatment for patients with certain forms of infertility refractory to current clinical strategies.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Nuno Costa-Borges

    R&D Department, Embryotools SL, Barcelona, Spain
    For correspondence
    nuno.borges@embryotools.com
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2073-7515
  2. Katharina Spath

    Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Irene Miguel-Escalada

    Genomics and Bioinformatics, Centre for Genomic Regulation, Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3461-6404
  4. Enric Mestres

    R&D Department, Embryotools SL, Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6140-6416
  5. Rosa Balmaseda

    Animal's Alliance Facility, Parc Cientific de Barcelona, Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
  6. Anna Serafín

    Animal's Alliance Facility, Parc Cientific de Barcelona, Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
  7. Maria Garcia-Jiménez

    R&D Department, Embryotools SL, Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3321-8869
  8. Ivette Vanrell

    R&D Department, Embryotools SL, Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
  9. Jesús González

    Animal's Alliance Facility, Parc Cientific de Barcelona, Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
  10. Klaus Rink

    R&D Department, Embryotools SL, Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
  11. Dagan Wells

    Nuffield Department of Women's and Reproductive Health, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  12. Gloria Calderón

    R&D Department, Embryotools SL, Barcelona, Spain
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3235-0323

Funding

European Regional Development Fund (RD-15-1-0011)

  • Nuno Costa-Borges

National Institutes of Health (1R01HD092550-01)

  • Dagan Wells

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Animal care and procedures were conducted according to protocols approved by the Ethics Committee on Animal Research (DAMM-7436) of the Parc Cientific of Barcelona (PCB), Spain.

Copyright

© 2020, Costa-Borges et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,085
    views
  • 404
    downloads
  • 25
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nuno Costa-Borges
  2. Katharina Spath
  3. Irene Miguel-Escalada
  4. Enric Mestres
  5. Rosa Balmaseda
  6. Anna Serafín
  7. Maria Garcia-Jiménez
  8. Ivette Vanrell
  9. Jesús González
  10. Klaus Rink
  11. Dagan Wells
  12. Gloria Calderón
(2020)
Maternal spindle transfer overcomes embryo developmental arrest caused by ooplasmic defects in mice
eLife 9:e48591.
https://doi.org/10.7554/eLife.48591

Share this article

https://doi.org/10.7554/eLife.48591

Further reading

    1. Cell Biology
    Kai-Ting Huang, Larry E Wagner ... David I Yule
    Research Advance

    The molecular mechanisms leading to saliva secretion are largely established, but factors that underlie secretory hypofunction, specifically related to the autoimmune disease Sjögren’s syndrome (SS) are not fully understood. A major conundrum is the lack of association between the severity of salivary gland immune cell infiltration and glandular hypofunction. SS-like disease was induced by treatment with DMXAA, a small molecule agonist of murine STING. We have previously shown that the extent of salivary secretion is correlated with the magnitude of intracellular Ca2+ signals (Takano et al., 2021). Contrary to our expectations, despite a significant reduction in fluid secretion, neural stimulation resulted in enhanced Ca2+ signals with altered spatiotemporal characteristics in vivo. Muscarinic stimulation resulted in reduced activation of the Ca2+-activated Cl- channel, TMEM16a, although there were no changes in channel abundance or absolute sensitivity to Ca2+. Super-resolution microscopy revealed a disruption in the colocalization of Inositol 1,4,5-trisphosphate receptor Ca2+ release channels with TMEM16a, and channel activation was reduced when intracellular Ca2+ buffering was increased. These data indicate altered local peripheral coupling between the channels. Appropriate Ca2+ signaling is also pivotal for mitochondrial morphology and bioenergetics. Disrupted mitochondrial morphology and reduced oxygen consumption rate were observed in DMXAA-treated animals. In summary, early in SS disease, dysregulated Ca2+ signals lead to decreased fluid secretion and disrupted mitochondrial function contributing to salivary gland hypofunction.

    1. Cell Biology
    2. Neuroscience
    Sara Bitar, Timo Baumann ... Axel Methner
    Research Article Updated

    Parkinson’s disease (PD) is characterized by the progressive loss of dopaminergic neurons in the substantia nigra of the midbrain. Familial cases of PD are often caused by mutations of PTEN-induced kinase 1 (PINK1) and the ubiquitin ligase Parkin, both pivotal in maintaining mitochondrial quality control. CISD1, a homodimeric mitochondrial iron-sulfur-binding protein, is a major target of Parkin-mediated ubiquitination. We here discovered a heightened propensity of CISD1 to form dimers in Pink1 mutant flies and in dopaminergic neurons from PINK1 mutation patients. The dimer consists of two monomers that are covalently linked by a disulfide bridge. In this conformation CISD1 cannot coordinate the iron-sulfur cofactor. Overexpressing Cisd, the Drosophila ortholog of CISD1, and a mutant Cisd incapable of binding the iron-sulfur cluster in Drosophila reduced climbing ability and lifespan. This was more pronounced with mutant Cisd and aggravated in Pink1 mutant flies. Complete loss of Cisd, in contrast, rescued all detrimental effects of Pink1 mutation on climbing ability, wing posture, dopamine levels, lifespan, and mitochondrial ultrastructure. Our results suggest that Cisd, probably iron-depleted Cisd, operates downstream of Pink1 shedding light on PD pathophysiology and implicating CISD1 as a potential therapeutic target.